Racial Differences in the Use of Respiratory Medications in Premature Infants after Discharge from the Neonatal Intensive Care Unit

Scott A. Lorch, Kelly C. Wade, Susan Bakewell Sachs, Barbara Medoff-Cooper, Gabriel J. Escobar, Jeffrey H. Silber

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To determine the effect of race and ethnicity on the use of oral beta-agonists, inhaled beta-agonists, and inhaled corticosteroids to treat respiratory symptoms in former premature infants after controlling for medical conditions, socioeconomic status, and site of outpatient care. Study design: Using a population cohort of infants born at a gestational age ≤34 weeks at 5 Northern California Kaiser Permanente hospitals between 1998 and 2001 (n = 1436), we constructed multivariable models to determine predictive factors for the receipt of respiratory medications during the first year after discharge. Results: After controlling for confounding factors, black infants were more likely to receive oral beta-agonists compared with white infants (OR 4.30, 95% CI 2.33-7.94), and Hispanic infants were less likely to receive inhaled beta-agonists (OR 0.62, 95% CI 0.39-0.99) or inhaled corticosteroids (OR 0.28, 95% CI 0.12-0.67). These findings were not explained by more outpatient visits for respiratory symptoms in black or Hispanic infants, because the observed racial differences persisted when children of similar respiratory symptoms were examined. Conclusions: Even in a high-risk population of insured infants, substantial racial differences persist in the use of respiratory medications that could not be explained by differences in respiratory symptoms.

Original languageEnglish (US)
JournalJournal of Pediatrics
Volume151
Issue number6
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Neonatal Intensive Care Units
Premature Infants
Hispanic Americans
Adrenal Cortex Hormones
Ambulatory Care
Social Class
Population
Gestational Age
Outpatients

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Racial Differences in the Use of Respiratory Medications in Premature Infants after Discharge from the Neonatal Intensive Care Unit. / Lorch, Scott A.; Wade, Kelly C.; Bakewell Sachs, Susan; Medoff-Cooper, Barbara; Escobar, Gabriel J.; Silber, Jeffrey H.

In: Journal of Pediatrics, Vol. 151, No. 6, 12.2007.

Research output: Contribution to journalArticle

Lorch, Scott A. ; Wade, Kelly C. ; Bakewell Sachs, Susan ; Medoff-Cooper, Barbara ; Escobar, Gabriel J. ; Silber, Jeffrey H. / Racial Differences in the Use of Respiratory Medications in Premature Infants after Discharge from the Neonatal Intensive Care Unit. In: Journal of Pediatrics. 2007 ; Vol. 151, No. 6.
@article{05de8c55700e41f18dc9c5066e5d8376,
title = "Racial Differences in the Use of Respiratory Medications in Premature Infants after Discharge from the Neonatal Intensive Care Unit",
abstract = "Objective: To determine the effect of race and ethnicity on the use of oral beta-agonists, inhaled beta-agonists, and inhaled corticosteroids to treat respiratory symptoms in former premature infants after controlling for medical conditions, socioeconomic status, and site of outpatient care. Study design: Using a population cohort of infants born at a gestational age ≤34 weeks at 5 Northern California Kaiser Permanente hospitals between 1998 and 2001 (n = 1436), we constructed multivariable models to determine predictive factors for the receipt of respiratory medications during the first year after discharge. Results: After controlling for confounding factors, black infants were more likely to receive oral beta-agonists compared with white infants (OR 4.30, 95{\%} CI 2.33-7.94), and Hispanic infants were less likely to receive inhaled beta-agonists (OR 0.62, 95{\%} CI 0.39-0.99) or inhaled corticosteroids (OR 0.28, 95{\%} CI 0.12-0.67). These findings were not explained by more outpatient visits for respiratory symptoms in black or Hispanic infants, because the observed racial differences persisted when children of similar respiratory symptoms were examined. Conclusions: Even in a high-risk population of insured infants, substantial racial differences persist in the use of respiratory medications that could not be explained by differences in respiratory symptoms.",
author = "Lorch, {Scott A.} and Wade, {Kelly C.} and {Bakewell Sachs}, Susan and Barbara Medoff-Cooper and Escobar, {Gabriel J.} and Silber, {Jeffrey H.}",
year = "2007",
month = "12",
doi = "10.1016/j.jpeds.2007.04.052",
language = "English (US)",
volume = "151",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Racial Differences in the Use of Respiratory Medications in Premature Infants after Discharge from the Neonatal Intensive Care Unit

AU - Lorch, Scott A.

AU - Wade, Kelly C.

AU - Bakewell Sachs, Susan

AU - Medoff-Cooper, Barbara

AU - Escobar, Gabriel J.

AU - Silber, Jeffrey H.

PY - 2007/12

Y1 - 2007/12

N2 - Objective: To determine the effect of race and ethnicity on the use of oral beta-agonists, inhaled beta-agonists, and inhaled corticosteroids to treat respiratory symptoms in former premature infants after controlling for medical conditions, socioeconomic status, and site of outpatient care. Study design: Using a population cohort of infants born at a gestational age ≤34 weeks at 5 Northern California Kaiser Permanente hospitals between 1998 and 2001 (n = 1436), we constructed multivariable models to determine predictive factors for the receipt of respiratory medications during the first year after discharge. Results: After controlling for confounding factors, black infants were more likely to receive oral beta-agonists compared with white infants (OR 4.30, 95% CI 2.33-7.94), and Hispanic infants were less likely to receive inhaled beta-agonists (OR 0.62, 95% CI 0.39-0.99) or inhaled corticosteroids (OR 0.28, 95% CI 0.12-0.67). These findings were not explained by more outpatient visits for respiratory symptoms in black or Hispanic infants, because the observed racial differences persisted when children of similar respiratory symptoms were examined. Conclusions: Even in a high-risk population of insured infants, substantial racial differences persist in the use of respiratory medications that could not be explained by differences in respiratory symptoms.

AB - Objective: To determine the effect of race and ethnicity on the use of oral beta-agonists, inhaled beta-agonists, and inhaled corticosteroids to treat respiratory symptoms in former premature infants after controlling for medical conditions, socioeconomic status, and site of outpatient care. Study design: Using a population cohort of infants born at a gestational age ≤34 weeks at 5 Northern California Kaiser Permanente hospitals between 1998 and 2001 (n = 1436), we constructed multivariable models to determine predictive factors for the receipt of respiratory medications during the first year after discharge. Results: After controlling for confounding factors, black infants were more likely to receive oral beta-agonists compared with white infants (OR 4.30, 95% CI 2.33-7.94), and Hispanic infants were less likely to receive inhaled beta-agonists (OR 0.62, 95% CI 0.39-0.99) or inhaled corticosteroids (OR 0.28, 95% CI 0.12-0.67). These findings were not explained by more outpatient visits for respiratory symptoms in black or Hispanic infants, because the observed racial differences persisted when children of similar respiratory symptoms were examined. Conclusions: Even in a high-risk population of insured infants, substantial racial differences persist in the use of respiratory medications that could not be explained by differences in respiratory symptoms.

UR - http://www.scopus.com/inward/record.url?scp=36148955095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36148955095&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2007.04.052

DO - 10.1016/j.jpeds.2007.04.052

M3 - Article

C2 - 18035139

AN - SCOPUS:36148955095

VL - 151

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 6

ER -